معرفی
Professor Douglas Joshua is a leading academic in Haematology and Immunology at the University of Sydney's Bosch Institute, affiliated with the Central Clinical School. Specializing in multiple myeloma and related hematological malignancies, his research focuses on tumor immunology, T-cell dynamics, and translational therapies. He has co-authored over 200 peer-reviewed articles and contributed to international treatment guidelines.
- Professor of Haematology
- Affiliated with Bosch Institute & Central Clinical School
- Member of the International Myeloma Working Group
Research interests include:
- T-cell dysfunction in myeloma
- Immunotherapy development
- Clinical trial design for novel agents
Publications emphasize T-cell subset analysis, therapeutic biomarkers, and treatment outcomes. Major contributions include defining prognostic factors in myeloma and advancing liquid biopsy techniques. Grants include high-throughput equipment for molecular analysis (NHMRC 2013, 2012).
Advising involves mentoring clinical researchers in oncology and hematology. Collaborations span global institutions including Mayo Clinic and MD Anderson.
